878207-28-4

Basic information

• Product Name: METHYL 2-BROMO-4,5-DIFLUOROBENZOATE
• Synonyms: METHYL 2-BROMO-4,5-DIFLUOROBENZOATE
• CAS NO: 878207-28-4
• Molecular Formula: C₈H₅BrF₂O₂
• Molecular Weight: 251.02
• Product Categories: Fluorine series
• Mol File: 878207-28-4.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 249.5°C at 760 mmHg
• Flash Point: 104.7°C
• Appearance: /
• Density: 1.652g/cm³
• Vapor Pressure: 0.0229mmHg at 25°C
• Refractive Index: 1.513
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: METHYL 2-BROMO-4,5-DIFLUOROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-BROMO-4,5-DIFLUOROBENZOATE(878207-28-4)
• EPA Substance Registry System: METHYL 2-BROMO-4,5-DIFLUOROBENZOATE(878207-28-4)

Safety Data

• Hazardous Substances Data: 878207-28-4(Hazardous Substances Data)

Usage

General Description

Methyl 2-bromo-4,5-difluorobenzoate is a chemical compound with the molecular formula C8H5BrF2O2. It is a pale yellow liquid with a sharp, pungent odor. METHYL 2-BROMO-4,5-DIFLUOROBENZOATE is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also used as a building block in the production of specialty chemicals. Methyl 2-bromo-4,5-difluorobenzoate is considered to be toxic to aquatic life and should be handled with care, using appropriate safety precautions in its production and handling.

InChI:InChI=1/C8H5BrF2O2/c1-13-8(12)4-2-6(10)7(11)3-5(4)9/h2-3H,1H3

Upstream product

• 145286-17-5 4,5-Difluoro-phthalic acid 1-methyl ester 2-(2-thioxo-2H-pyridin-1-yl) ester 
• 942-06-3 4,5-dichlorophthalic anhydride 
• 18959-30-3 4,5-difluorophthalic anhydride 
• 145286-16-4 2-Chlorocarbonyl-4,5-difluoro-benzoic acid methyl ester 
• 67-56-1 methanol 
• 64695-84-7 2-bromo-4,5-difluorobenzoic acid 
• 74-88-4 methyl iodide 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 64695-84-7 2-bromo-4,5-difluorobenzoic acid 
• 1196693-82-9 methyl 4-(benzylamino)-2-bromo-5-fluorobenzoate 
• 476620-55-0 (2-bromo-4,5-difluorophenyl)methanol 
• 1309069-02-0 methyl 4-(5-(benzyloxy)-1H-indol-1-yl)-2-bromo-5-fluorobenzoate 
• 1309068-78-7 6-(5-(benzyloxy)-1H-indol-1-yl)-5-fluorobenzo[c][1,2]oxaborol-1(3H)-ol 
• 1309069-03-1 (4-(5-(benzyloxy)-1H-indol-1-yl)-2-bromo-5-fluorophenyl)methanol 
• 1374150-50-1 4,5-difluoro-2-formylbenzoic acid 
• 1374149-79-7 2-[5-(2-amino-pyrimidin-5-yl)-1-tert-butyl-1H-benzoimidazol-2-yl]-4,5-difluoro-N-methyl-benzamide 
• 1374150-51-2 C₂₂H₁₉F₂N₅O₂ 
• 1379005-23-8 methyl 4,5-difluoro-2-((4-methoxyphenyl)ethynyl)benzoate 
• 1415022-93-3 2-butyl-4-chloro-1-((4',5'-difluoro-2'-(methoxycarbonyl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid 
• 1415022-88-6 C₂₂H₁₉ClF₂N₂O₄ 

Relevant articles and documents

NOVEL SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES WITH ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF

The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.

Chroman derivatives having estrogen receptor degradation activity and uses thereof

The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions.

Synthesis and antimicrobial evaluation of amixicile-based inhibitors of the pyruvate-ferredoxin oxidoreductases of anaerobic bacteria and Epsilonproteobacte

Amixicile is a promising derivative of nitazoxanide (an antiparasitic therapeutic) developed to treat systemic infections caused by anaerobic bacteria, anaerobic parasites, and members of the Epsilonproteobacteria (Campylobacter and Helicobacter). Amixicile selectively inhibits pyruvate-ferredoxin oxidoreductase (PFOR) and related enzymes by inhibiting the function of the vitamin B1 cofactor (thiamine pyrophosphate) by a novel mechanism. Here, we interrogate the amixicile scaffold, guided by docking simulations, direct PFOR inhibition assays, and MIC tests against Clostridium difficile, Campylobacter jejuni, and Helicobacter pylori. Docking simulations revealed that the nitro group present in nitazoxanide interacts with the protonated N4′-aminopyrimidine of thiamine pyrophosphate (TPP). The ortho-propylamine on the benzene ring formed an electrostatic interaction with an aspartic acid moiety (B456) of PFOR that correlated with improved PFOR-inhibitory activity and potency by MIC tests. Aryl substitution with electron-withdrawing groups and substitutions of the propylamine with other alkyl amines or nitrogen-containing heterocycles both improved PFOR inhibition and, in many cases, biological activity against C. difficile. Docking simulation results correlate well with mechanistic enzymology and nuclear magnetic resonance (NMR) studies that show members of this class of antimicrobials to be specific inhibitors of vitamin B1 function by proton abstraction, which is both novel and likely to limit mutation-based drug resistance.